>



Plenary Lecture

  • Plenary Lecture 1 Overcoming resistance to checkpoint blockade immunotherapy
    Jedd WOLCHOK MSKCC USA CV
  • Plenary Lecture 2 Sharing experiences and establishment of guidelines of cancer care in COVID-19 pandemic
    Giuseppe CURIGLIANO University of Milano Italy CV
  • Plenary Lecture 3 Tumor heterogeneity and treatment resistance
    Joan S BRUGGE Harvard Medical School USA CV
  • Plenary Lecture 4 Drug development in
    oncology: the revolution of
    the last 15 years
    Jean-Charles SORIA Amgen France CV


Scientific Symposium

Scientific Symposium 1 Immunotherapy beyond anti-PD1/PDL1 antibody
  • James MOON University of Michigan USA CV
  • Chan KIM CHA Bundang Medical Center Korea CV
  • Melissa JOHNSON Sarah Cannon Research Institute USA CV
  • Jeffrey S. Weber NYU School of Medicine USA CV
Scientific Symposium 2 Resistance mechanism of immunotherapy
  • Se-Hoon LEE Samsung Medical Center Korea CV
  • Ross Andrew Soo National University
    of Singapore
    Singapore CV
  • Hye Ryun KIM Yonsei Cancer Center Korea CV
  • Yong LU Wake Forest School of Medicine USA CV
Scientific Symposium 3 Expanding indications of PARP inhibitors
  • Kyung-Hun LEE Seoul National University Hospital Korea CV
  • Mark J O'CONNOR AstraZeneca UK CV
  • Amit M. OZA University of Toronto Canada CV
  • Timothy A. Yap The University of Texas MD Anderson Cancer Center USA CV
Scientific Symposium 4 Targeting endocrine pathway: Breast & Prostate
  • Yoon-Sim YAP National Cancer
    Centre Singapore
    Singapore CV
  • Bora LIM Baylor College of Medicine USA CV
  • Inkeun PARK Gachon University
    Gil Medical Center
    Korea CV
  • Jae Lyun LEE Asan Medical Center Korea CV
Scientific Symposium 5 Recent advances in NSCLC & SCLC
  • Byoung Chul CHO Yonsei Cancer Center Korea CV
  • Dong-Wan KIM Seoul National University Hospital Korea CV
  • Martin SEBASTIAN University Hospital Frankfurt Germany CV
  • Niels REINMUTH Asklepios Lung Clinic Germany CV
Scientific Symposium 6 Recent advances in Stomach cancer & GIST
  • Keun-Wook LEE Seoul National University Bundang Hospital Korea CV
  • Kohei SHITARA National Cancer Center Hospital East Japan CV
  • Hyo Song KIM Severance Hospital Korea CV
Scientific Symposium 7 Recent advances in Hepatocellular carcinoma/Pancreas-Biliary Ca
  • Ghassan ABOU-ALFA MSKCC USA CV
  • Do-Youn OH Seoul National University Hospital Korea CV
  • Teresa MACARULLA VHIO Spain CV
Scientific Symposium 8 Infection and cancer: HBV, HIV, HPV, CMV etc
  • Thomas F. MEYER Max Planck Institute for Infection Biology Germany CV
  • Valerie Chew Suk PENG Translational Immunology Institute (TII) Singapore CV
  • KC Allen CHAN The Chinese University of Hong Kong HK CV
Scientific Symposium 9 Clinical application of ctDNA profile
  • Seung-Tae LEE Yonsei University College of Medicine Korea CV
  • Sun-Young KONG National Cancer Center Korea CV
  • Sarat CHANDARLAPATY MSKCC USA CV


Joint Symposium

ASCO/KSMO Joint Symposium 1 Integrating next-generation sequencing into clinical practices: sharing the real-world experiences
  • Lillian L. Siu Princess Margaret
    Cancer Centre
    Canada CV
  • Vivek Subbiah The University of Texas MD Anderson Cancer Center USA
  • Kyong Hwa PARK Korea University Anam Hospital Korea CV
ASCO/KSMO Joint Symposium 2 Ladder of Cancer treatment : Precision medicine and Palliative care
  • Rodabe N. Amaria The University of Texas MD Anderson Cancer Center USA CV
  • Yeon Hee PARK Samsung Medical Center Korea
  • Ishwaria Mohan Subbiah The University of Texas MD Anderson Cancer Center USA
  • Jung Hye KWON Chungnam National University Sejong Hospital Korea CV
ESMO/KSMO Joint Symposium Updates of IO Treatments and Asian subgroup analysis in oncology clinical trials
  • Bhumsuk KEAM Seoul National University Hospital Korea CV
  • Nicolas GIRARD Institute Curie France CV
  • Elizabeth SMYTH Cambridge University Hospitals NHS Foundation Trust UK CV
  • Seock-Ah IM Seoul National University Hospital Korea
JSMO/KSMO Joint Symposium Biomarker driven clinical trials : sharing experiences
  • Minkyu JUNG Yonsei Cancer Center Korea CV
  • Yoshiaki NAKAMURA National Cancer Center Hospital East Japan CV
  • Myung-Ju AHN Samsung Medical Center Korea CV
  • Akinobu HAMADA National Cancer Center Research Institute Japan CV
KOSRO/KSMO Joint Symposium De-escalation/Escalation of radiotherapy
  • Yong Bae KIM Yonsei University College of Medicine Korea CV
  • Sue YOM UCSF USA CV
  • Ken KATO National Cancer Center Hospital Japan CV
  • Sung-Ja AHN Chonnam National University Medical School Korea CV
KCSG/KSMO Joint Symposium Conducting phase I clinical trial with targeted therapy/immunotherapy
  • Chan-Young OCK Bang&Oak Consulting Korea CV
  • Jonathan SUN Norvatis Oncology China CV
  • Jee Hyun KIM Seoul National University Bundang Hospital Korea CV
KSP/KSMO Joint Symposium Tumor microenvironment and pathology
  • Seung Yeon YOO Asan Medical Center Korea CV
  • Yoonjin KWAK Seoul National University Hospital Korea CV
  • Mark Borris D. ALDONZA Seoul National University Korea CV
  • Alex SWARBRICK Garvan Institute of Medical Research Australia CV
KSSO/KSMO Joint Symposium Multimodality Treatment Stretegy : Breast surgery in stage IV BC, Neoadj. CTx followed by surgery in LAPC-
  • Jin-Young JANG Seoul National University Hospital Korea CV
  • Changhoon YOO Asan Medical Center Korea CV
  • So Youn JUNG National Cancer Center Korea CV
  • Han Jo KIM Sonnchunhyang University Cheonan Hospital Korea CV
KSR/KSMO Joint Symposium State-of-the-art oncologic imaging analysis
  • Kyung Won KIM Asan Medical Center Korea CV
  • Ho Yun LEE Samsung Medical Center Korea CV
  • Hongyoon CHOI Seoul National University Hospital Korea CV


Multidisciplinary Oncology Team Education Session

MDT (Oncology Multi-Disciplinary Symposium)
KOR
Korean Session
Treatment for brain/bone metastasis
  • TBD
  • TBD
  • TBD


Multidisciplinary Oncology Team Education Session 1
KOR
Korean Session
Current strategies for maximizing the benefit of immunotherapy
  • Seung Hoon BEOM Yonsei Cancer Center Korea CV
  • Ji Hyun PARK Konkuk Medical University Hospital Korea CV
  • Hong Jae CHON Cha Bundang Medical Center Korea CV
Multidisciplinary Oncology Team Education Session 2
KOR
Korean Session
Targeted therapy : clinical effects and resistance
  • Jina YUN Soon Chun Hyang University Hospital Bucheon Korea CV
  • Jae Ho JEONG Asan Medical Center Korea
  • Hyewon RYU Chungnam National University Korea CV
Multidisciplinary Oncology Team Education Session 3
KOR
Korean Session
Advances in toxicity management
  • Byoung Soo KWON Seoul National University Bundang Hospital Korea CV
  • Hyemi KWON Kangbuk Samsung Hospital Korea CV
  • Chong Won CHOI Seoul National University Bundang Hospital Korea CV
  • Jeong Il YU Samsung Medical Center Korea CV


Special Symposium

  • Yun-Gyoo LEE Kangbuk Samsung Hospital Korea CV
  • Chi Young SHIM Severance Hospital Korea CV
  • Eun Kyoung KIM Samsung Medical Center Korea CV
  • Peter Y. KIM The University of Texas MD Anderson Cancer Center USA CV